QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 35 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $117,000 | – | 127,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighMark Wealth Management LLC | 80,094 | $104,000 | 0.08% |
| PERKINS CAPITAL MANAGEMENT INC | 51,178 | $67,000 | 0.04% |
| HATTON CONSULTING, INC. | 27,195 | $35,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 78,687 | $102,000 | 0.01% |
| CRA Financial Services, LLC | 19,957 | $26,000 | 0.01% |
| Virtu Financial LLC | 25,507 | $33,000 | 0.00% |
| WEDBUSH SECURITIES INC | 32,228 | $42,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,347 | $20,000 | 0.00% |
| UBS Group AG | 13,118 | $17,000 | 0.00% |
| US BANCORP \DE\ | 9,047 | $12,000 | 0.00% |